Title of article :
The Effect of Anticholinergics for Prevention of Storage Symptoms After Prostate Photovaporization
Author/Authors :
Alejandro Martín Way, David Urology Department - Hospital Universitario Virgen de las Nieves - Avenida de las fuerzas armadas - nº2 18014 - Granada (España) , Barrabino Martín, Rocio Urology Department - Hospital Universitario Virgen de las Nieves - Avenida de las fuerzas armadas - nº2 18014 - Granada (España) , Puche Sanz, Ignacio Urology Department - Hospital Universitario Virgen de las Nieves - Avenida de las fuerzas armadas - nº2 18014 - Granada (España) , Javier Vicente Prados, Francisco Urology Department - Hospital Universitario Virgen de las Nieves - Avenida de las fuerzas armadas - nº2 18014 - Granada (España) , Manuel Cozar Olmo, Jose Urology Department - Hospital Universitario Virgen de las Nieves - Avenida de las fuerzas armadas - nº2 18014 - Granada (España)
Abstract :
Purpose: To evaluate the efficacy of oral anticholinergics as a preventive strategy of storage symptoms and urinary
incontinence associated with the early postoperative period after Greenlight laser photovaporization of the
prostate (PVP). To analyze potential variables related to the onset of these symptoms.
Materials and methods: Retrospective study of 105 patients who underwent PVP using a 180-W Greenlight laser
(XPS). Patients were divided into two groups, depending on whether they were or weren´t prescribed anticholinergics
when discharged (oral solifenacin 5 mg for 1 month after surgery). Differences between both groups were
analyzed according to IPSS, ICIQ-SF and OABq-SF scores at 1 and 6 months. The potentially predictive variables
of the symptomatology after undergoing PVP that we analyzed included age, prostate volume, PSA, IPSS, ICIQSF,
OABq-SF, Qmax, previous use of a permanent urinary catheter, energy used, and laser application time.
Results: 58 patients in the group with anticholinergics and 47 in the group without anticholinergics were compared.
No significant differences were observed between both groups in IPSS (p = .521), ICIQ-SF (p = .720) or
OABq-SF (p = .851) at 1 and 6 months after surgery. Regardless of the use of anticholinergics, there was a significant
score improvement between the first and second checkup in all the questionnaires: there was a significant
decrease in the mean IPSS (p < .001) and the mean score of the eighth IPSS question on patient’s quality of life
(p = .026), ICIQ- SF (p = .010) and OAB-q related to symptoms (p = .001) as well as a significant increase in the
mean OAB-q score regarding quality of life (p = .005). None of the variables analyzed showed a significant relation
to the storage-symptom rate, rate of incontinence, or ICIQ-SF and OABq-SF scores.
Conclusion: The use of solifenacin 5 mg after Greenlight laser PVP is not an effective preventive treatment for
storage and incontinence symptoms associated with this procedure, which seem to self-limit over time.
Keywords :
anticholinergics , greenlight laser , oral anticholinergigs , prostate , storage symptoms
Journal title :
Urology Journal